This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
by Zacks Equity Research
UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019
UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy
by Sweta Killa
ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.
Stock Market News For Jan 16, 2019
by Zacks Equity Research
Benchmarks ended in the green on Tuesday as Netflix buoyed gains for the broader markets.
The Earnings Story So Far & What To Watch During Q4 Report Season
by Ryan McQueeney
Ryan McQueeney recaps Netflix's subscription price hike and earnings results from Delta, UnitedHealth, Wells Fargo, and JPMorgan. Later, he chats with Dave Bartosiak about bank earnings and how investors can profit throughout the Q4 report season.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
PPI Joins Q4 Reports for JPM, WFC & More; Big Day for Data
by Mark Vickery
Currently, Q4 earnings season is heating up in earnest, with two top Wall Street banks and two other sector leaders bringing results ahead of the opening bell.
UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.
UnitedHealth Group (UNH) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
A Look at Dow ETF Ahead of Q4 Earnings
by Sweta Killa
Let's delve into the Q4 earnings picture that will likely set up the movement of Dow Jones ETF in the coming days.
What's in the Cards for UnitedHealth (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 performance should benefit from robust segmental revenues along with membership growth.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $244.70 in the latest trading session, marking a +0.44% move from the prior day.
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
by Zacks Equity Research
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
Why Does the Stock of Cigna (CI) Look Attractive Now?
by Zacks Equity Research
The acquisition of Express Scripts by Cigna (CI) presents another major growth point for the company.
These 5 Companies are Earnings Perfection
by Tracey Ryniec
Looking for only the best this earnings season? These companies haven't missed on earnings in the last 5 years.
Dow Posts Longest Winning Run Since November: 5 Top Picks
by Nalak Das
The Dow - commenced 2019 on a brighter note. Positive developments on trade war front and Fed???s monetary stance are likely to boost investor sentiment in the near-term resulting in further consolidation of the index.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $239.62, marking a +1.17% move from the previous day.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Top Analyst Reports for UnitedHealth, CVS Health & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $246.24 in the latest trading session, marking a +0.11% move from the prior day.
5 Worst Performing Stocks of Dow ETF Last Week
by Sweta Killa
Dow Jones suffered its worst week since the global financial crisis of 2008. We have highlighted five worst-performing stocks in the ETF.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $252.97, moving -1.98% from the previous trading session.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Will Lower Revenues Hurt BlackBerry's (BB) Q3 Earnings?
by Zacks Equity Research
BlackBerry (BB) is likely to report lower year-over-year revenues in the fiscal third quarter, primarily due to negative impact of the changes in the accounting and sales model.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling